SMAD2 and Hepatic fibrosis: A recent study reveals that the expression of C-myc and Smad2/3 are upregulated in LPS-treated hepatic stellate cells, while the expression of recombinant thrombospondin 1 and phosphorylation of STAT3 is upregulated in the hepatocytes of mice with liver fibrosis [77].